Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Molecular Endocrinology (Baltimore, Md.)
|
July 1, 1988
Glucocorticoid regulation of enkephalins in cultured rat adrenal medulla
C E Inturrisi, A D Branch, H D Robertson, et al.
Hepatology (Baltimore, Md.)
|
October 26, 2000
Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine
A Tanaka, G Nalbandian, P S Leung, et al.
Journal of Viral Hepatitis
|
March 19, 2016
High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens
P V Perumalswami, N Patel, K Bichoupan, et al.
Alimentary Pharmacology & Therapeutics
|
November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir
K Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply
K Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Molecular Endocrinology (Baltimore, Md.)
|
July 1, 1988
Glucocorticoid regulation of enkephalins in cultured rat adrenal medulla
C E Inturrisi, A D Branch, H D Robertson, et al.
Hepatology (Baltimore, Md.)
|
October 26, 2000
Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine
A Tanaka, G Nalbandian, P S Leung, et al.
Journal of Viral Hepatitis
|
March 19, 2016
High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens
P V Perumalswami, N Patel, K Bichoupan, et al.
Alimentary Pharmacology & Therapeutics
|
November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir
K Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply
K Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Page
of 5